Pretransplant C-peptide Levels and Pancreas Transplant Outcomes: Risk and Reward
- PMID: 37097983
- DOI: 10.1097/TP.0000000000004566
Pretransplant C-peptide Levels and Pancreas Transplant Outcomes: Risk and Reward
Conflict of interest statement
The authors declare no funding or conflicts of interest.
Comment on
-
Higher Fasting Pretransplant C-peptide Levels in Type 2 Diabetics Undergoing Simultaneous Pancreas-kidney Transplantation Are Associated With Posttransplant Pancreatic Graft Dysfunction.Transplantation. 2023 Apr 1;107(4):e109-e121. doi: 10.1097/TP.0000000000004489. Epub 2023 Jan 5. Transplantation. 2023. PMID: 36706060 Review.
References
-
- Parajuli S, Mandelbrot D, Aufhauser D, et al. Higher fasting pretransplant C-peptide levels in type 2 diabetics undergoing simultaneous pancreas-kidney transplantation are associated with posttransplant pancreatic graft dysfunction. Transplantation. 2023. doi: 10.1097/TP.0000000000004489 - DOI
-
- Stratta RJ, Farney AC, Fridell JA. Analyzing outcomes following pancreas transplantation: definition of a failure or failure of a definition. Am J Transplant. 2022;22:1523–1526.
-
- Gurram V, Gurung K, Rogers J, et al. Do pretransplant C-peptide levels influence outcomes in simultaneous pancreas-kidney transplantation? A matched case-control study. Clin Transplant. 2021;35:e14498.
-
- Fridell JA, Stratta RJ, Gruessner A. Pancreas transplantation: current challenges, considerations, and controversies. J Clin Endocrinol Metab. 2022;15:dgac644.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
